Integrated Solution will Provide RamSoft Customers with Seamless Access to Advanced AI Capabilities to Improve Cancer Detection and Streamline Radiologist Workflows
RamSoft Inc., a leader in cloud-based RIS/PACS platforms, and Therapixel, the award-winning medical imaging AI company, announces a commercial partnership to integrate Therapixel’s AI-powered MammoScreen software directly into RamSoft’s PowerServer and OmegaAI platforms. The announcement is being made during the SIIM 2025 Annual Meeting, taking place May 21–23 at the Portland Convention Center in Portland, Oregon. RamSoft is exhibiting at Booth #639, and Therapixel at Booth #435.
Health Technology Insights: Avant and Ainnova in Talks for Preventative Health Tech
This collaboration will make Therapixel’s MammoScreen, an industry-leading breast imaging solution, available natively within RamSoft’s platforms. Customers will have with seamless access to advanced AI capabilities designed to improve cancer detection, streamline radiologist workflow, and ultimately enhance women’s health services.
“We’re thrilled to partner with Therapixel to bring their proven, AI-powered MammoScreen technology to our customers,” said Vijay Ramanathan, CEO and Co-Founder of RamSoft. “This integration reflects our mission to deliver intelligent imaging solutions that empower radiologists with the best tools available, all within a single, efficient cloud platform. Our collaboration with Therapixel marks a pivotal step in enhancing diagnostic confidence and clinical productivity in breast imaging.”
Health Technology Insights: NorthX Biologics Secures Significant Growth Investment from Signet Healthcare Partners
MammoScreen enhances the breast imaging workflow through three key AI-driven capabilities:
- Pre-check – Ensures optimal image quality and confirms key patient information prior to reading.
- Cancer Detection – Provides comprehensive analysis for detecting and characterizing lesions, and incorporates previous imaging and a breast density assessment.
- Pre-reporting – Populates structured results into existing reporting systems, reducing documentation time and effort.
A recent clinical study of MammoScreen using 2D, 3D, and prior images demonstrated measurable improvements in radiologist performance: an 8% increase in sensitivity, a 2% boost in specificity, and average reading and reporting time reductions of 24%. In another study, MammoScreen demonstrated finding screen detectable cancer one year prior 42% of the time, and two years prior 38.5% of the time.
“At Therapixel, our mission has always been to provide radiologists with technology that makes them more accurate and confident in their decisions,” said Matthieu Leclerc-Chalvet, CEO of Therapixel. “By partnering with RamSoft, we can now deliver MammoScreen to a broader audience, embedded directly within PACS platforms that radiologists already use. This deep integration dramatically simplifies the user experience and enhances clinical value, especially in women’s health.”
This partnership not only underscores both companies’ commitment to innovation, it also highlights the value of open platforms in scaling access to leading-edge medical AI tools. With this integration, radiologists can now leverage MammoScreen as a turnkey solution embedded directly into their existing PACS workflows. No additional systems or interfaces are required.
Health Technology Insights: Dale Carr Joins Alivia Analytics from Missouri Medicaid Audit and Compliance
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
